Systemic Therapy of Primary Cutaneous B-cell Lymphoma, Marginal Zone Type, with Rituximab, a Chimeric Anti-CD20 Monoclonal Antibody
Open Access
- 1 June 2001
- journal article
- Published by Medical Journals Sweden AB in Acta Dermato-Venereologica
- Vol. 81 (3) , 207-208
- https://doi.org/10.1080/000155501750376339
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: